Table 3 |
||||
|
Physical status of HPV-16 in lung carcinomas |
||||
|
Case |
E6 Copies/100 ng |
E2 Copies/100 ng |
E2/E6 |
Physical status |
|
|
||||
|
1 |
411 |
0 |
0 |
Integrated |
|
2 |
1737 |
35 |
0.02 |
Mixed |
|
3 |
2139 |
0 |
0 |
Integrated |
|
4 |
1724 |
0 |
0 |
Integrated |
|
5 |
1384 |
7.6 |
0.0055 |
Mixed |
|
6 |
1876 |
0 |
0 |
Integrated |
|
7 |
2345 |
0 |
0 |
Integrated |
|
8 |
42141 |
21071 |
0.5 |
Mixed |
|
|
||||
|
Aguayo et al. Infectious Agents and Cancer 2010 5:20 doi:10.1186/1750-9378-5-20 |
||||
